140,000 documents transformed into 60,000 structured records since go-live SYDNEY, Sept. 29, 2025 -- Newgen Software, a global provider of an AI-first unified digital transformation platform, announced that Macquarie University Health has successfully gone live with Newgen's Content Management and Process Automation Platform to modernise patient document processing. Leveraging Newgen's AI-first Contextual Content Services (ECM) and Intelligent Process Automation (BPM) Platforms, the Sydney-based healthcare firm revamped records management across its hospital network. AI
HONG KONG, Sept. 29, 2025 -- Since 2025, the medical and healthcare sector have become a hot investment target in Hong Kong capital market. According to the Hang Seng Index Company, the healthcare industry has surged by as much as 91.2% from the beginning of the year until late August, making it the best-performing sector among the 12 industry indices of the Hang Seng Composite Index. Among healthcare-related stocks, Home Control(1747.HK) has shown strong growth potential following its expansion from smart home IoT to home medical fields, backed by its solid background of experiences in Europ
BEIJING, Sept. 28, 2025 -- A news report from Xinhua Finance, "Over the past few years, we have seen China gradually increase its universal health coverage, boost investment, and place great emphasis on preventive medicine. While advancing its 'Healthy China 2030' initiative, China has built a high-quality healthcare system," said Martin Taylor, representative of the World Health Organization (WHO) in China. The WHO is very willing to collaborate with China, focusing on grassroots healthcare and the needs of the public to better meet the diagnostic and treatment needs concerning non
[ 메디채널 김갑성 기자 ] 타이베이, 2025년 9월 27일 -- 테스칸 그룹(Tescan Group)이 오늘 초고속 레이저 기술 분야를 선도하는 혁신 기업인 펨토이노베이션즈(FemtoInnovations)를 인수하고 코네티컷대학교 기술 단지(UConn Tech Park)에 레이저 기술 전담 사업부(LT BU)를 신설한다고 발표했다. 신생 사업부의 임무는 반도체, 생체 의료 기기 제조, 첨단 연구 분야를 겨냥한 테스칸의 상관관계 분석 및 다중 모드 포트폴리오를 확장하는 것이다. 펨토이노베이션즈 인수로 테스칸은 독창적이고 혁신적인 레이저 플랫폼을 확보하게 되었다. 이 플랫폼은 이미 까다로운 워크플로에서 검증을 마쳤고, 반도체, 첨단 제조, 첨단 기술 산업 분야를 이끄는 다국적 기업들로부터 지대한 관심을 받고 있다. 테스칸 그룹의 장샤를 첸(Jean-Charles Chen) 최고경영자(CEO)는 "펨토이노베이션즈가 테스칸 패밀리에 합류한 것은 토털 워크플로 솔루션 기술력을 강화하려는 취지에서 내린 전략적 결단이다. 초고속 레이저 마이크로머시닝(Laser Micromachining) 기술에 업계 최고를 다
SINGAPORE, Sept. 27, 2025 -- The 2025 BPD (Biopharmaceutical Bioprocess Development) Singapore Summit, which co-hosted by WuXi XDC (Stock Code: 2268.HK), was successfully concluded from September 24-26, 2025. The conference brought together leading biopharmaceutical companies and research institutions from Europe, North America, China, and the Asia-Pacific region. The conference aimed to facilitate exchanges and cooperation between Chinese and global biopharmaceutical enterprises and research institutions, and promote the application of advanced process technologies in the manufacturing of in
[ 메디채널 김갑성 기자 ] Joint research achievement by Gemelli Hospital in Rome, COREE, COREE Pohang, and the Università Cattolica del Sacro Cuore SEOUL, South Korea, Sept. 26, 2025 -- COREE announced on September 15 that it had, for the first time in the world, identified microbiome biomarkers specific to diabetes and obesity patients, in collaboration with Italian research teams. The company is led by Chairman Chong-Yoon Lim, who is also the largest shareholder of Dx&Vx. The announcement was made at the 38th Annual Workshop of the European Helicobacter & Microbiota S
TAIPEI, Sept. 26, 2025 -- Tescan Group today announced the acquisition of FemtoInnovations, a leading innovator in ultrafast laser technologies, and the creation of a dedicated Laser Technology Business Unit (LT BU) headquartered at the University of Connecticut (UConn) Tech Park. The new unit expands Tescan's correlative and multimodal portfolio for semiconductor, biomedical device manufacturing, and advanced research markets. FemtoInnovations brings to TESCAN a unique and disruptive laser platform — technology already proven in demanding workflows and attracting strong inter
FILSPARI® (sparsentan) suggested for IgA Nephropathy patients who are at risk of progressive kidney function loss ST. GALLEN, Switzerland, and SAN DIEGO, Sept. 26, 2025 -- CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) support the recent publication of the updated clinical practice guidelines for the treatment of IgA Nephropathy (IgAN), Kidney Disease: Improving Global Outcomes (KDIGO) 2025 clinical practice guideline for the management of IgA Nephropathy and Immunoglobulin A vasculitis. The updated guidelines define diagnostic criteria, treatment goals and treatm
MELBOURNE, Australia, Sept. 26, 2025 -- Titomic Limited (ASX: TTT), a global leader in Titomic Kinetic Fusion™, a cold spray additive manufacturing technology, is pleased to announce the appointment of Aude Vignelles as President of the Asia-Pacific Region (APAC), based in Melbourne. Ms. Vignelles brings an exceptional track record in aerospace, space, telecommunications, and advanced technology sectors, further strengthening Titomic's executive leadership during a pivotal period of regional growth and transformation. Aude Vignelles is the former Chief Technology Officer of the
SURABAYA, Indonesia, Sept. 26, 2025 -- Tourism Malaysia, in collaboration with the Malaysia Healthcare Travel Council (MHTC), proudly presents Malaysia Fair 2025—a four-day celebration of Malaysia's culture, cuisine, tourism, and healthcare excellence. Taking place at Pakuwon Mall, Surabaya from 25 to 28 September 2025, the event marks the first-ever partnership between Tourism Malaysia and MHTC in support of Visit Malaysia 2026 (VM2026) and the Malaysia Year of Medical Tourism 2026 (MYMT2026) campaigns. Malaysia Fair 2025 positions Malaysia as both a premier leisure destinatio